Sept. 21, 2012
-- Seattle, WA - Thanks to its impeccable reputation and its third party verification of quality control with micro-needling techniques, Dermaroller ® will be the ONLY micro-needling company to exhibit at the “world’s most respected and largest skin show” September 27-30, at the 21st Annual EADV (European Academy of Dermatology and Venereology)
Congress. The event will be held in Prague, capital of the Czech Republic, with the theme: “Skin is Vital.”
Local and international experts will present high-level information to Congress attendees covering topics such as basic and clinical dermatology, skin and skin cancer surgery, cosmetic dermatology, and skin infections. Other companies attending include: Abbott Laboratories, Syneron, Novartis, La Roche-Posay, Merck, Pfizer, and the American Academy of Dermatology (AAD).
“We’re proud to say that Dermaroller is continuing to grow, despite the presence of ‘knock-offs’
in the market-place,”
says Phillip Terrazas, Director of Sales & Marketing for Dermaroller US. He believes the amazing results patients regularly experience with Dermaroller medical micro-needling devices, whether in acne scar treatment or anti-aging skin procedures such as reduction of wrinkles and skin tightening, are the reason Dermaroller has been selected as the only micro-needling treatment provider invited to attend this year’s EADV Congress.
Less than 15 years ago, Horst Liebl began researching, engineering, and perfecting the micro-needling concept –resulting in the development of the Original Dermaroller. Since the founding of the company in 2000, Dermaroller has been the subject of numerous studies worldwide. It is now considered not only the original pioneer in this field, but also the leader in micro-needling technology. Dermaroller is also proud to acknowledge that they are the only micro needle company that is both CE (Conformité Européenne)
and TGA (Therapeutics Goods Administration-
Australia) Class 2 Medial Device listing in the world. No other micro-needle company has established their quality with any of these governmental bodies.
Micro-needling involves the use of ultra-fine, sterile, surgical-strength micro-needles. In a procedure called Collagen Induction Therapy (CIT), the Medical Dermaroller uses these needles to cause new collagen, elastin and tissue matrix to be deposited in the deep skin layers, new capillaries to be formed, and new skin cells to be created. To learn more about the Medical Dermaroller, visit http://www.dermarollerus.com/patient/official-medical-der...
Based in Germany, Dermaroller ® has been in the United States since 2003, with an active trademark since 2008. The U.S. branch of the company, Dermaroller US, sells medical Dermaroller micro-needling rollers to qualified medical professionals who have completed our training program. It also has a staff that supports, educates, and promotes the legal, proper, and most efficient and ethical way to use and apply skin micro-needling devices. (While medical Dermarollers are designed for sterile single-use and are only sold to qualified medical professionals, Dermaroller US does distribute a home use version micro-needling roller to the public that is reusable.)
Cynergy, LLC is the exclusive U.S. distributor of Dermaroller ®. For more information, please visit www.dermarollerus.com.